We serve Chemical Name:5-(Aminosulfonyl)-1-Methyl-1H- Pyrazole-4-Carbo CAS:88398-83-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-(Aminosulfonyl)-1-Methyl-1H- Pyrazole-4-Carbo
CAS.NO:88398-83-8
Synonyms:5-(aminosulfonyl)-1-methyl-1H- pyrazole-4-carbo;Methyl 1-methyl-5-sulfamoyl-1H-pyrazole-4-carboxylate;1H-Pyrazole-4-carboxylic acid, 5-(aminosulfonyl)-1-methyl-, methyl ester
Molecular Formula:C6H9N3O4S
Molecular Weight:219.218
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:447.7±55.0 °C at 760 mmHg
Density:1.6±0.1 g/cm3
Index of Refraction:1.631
PSA:112.66000
Exact Mass:219.031372
LogP:-1.53
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-(aminosulfonyl)-1-methyl-1H- pyrazole-4-carbo chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1H-Pyrazole-4-carboxylic acid, 5-(aminosulfonyl)-1-methyl-, methyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1H-Pyrazole-4-carboxylic acid, 5-(aminosulfonyl)-1-methyl-, methyl ester Use and application,5-(aminosulfonyl)-1-methyl-1H- pyrazole-4-carbo technical grade,usp/ep/jp grade.
Related News: Right now, midstage data for Roche-AC Immune’s anti-tau antibody semorinemab in moderate Alzheimer’s are expected later this year, but it has already failed a phase 2 study in mild disease. 5-(Aminosulfonyl)-1-Methyl-1H- Pyrazole-4-Carbo manufacturer Of the nearly 4,000 Black women and more than 25,000 white women included in the study, there was no statistically significant difference in breast cancer-related genetic mutations. They were found in 5.65% of Black women and nearly 5.1% of white women. 5-(Aminosulfonyl)-1-Methyl-1H- Pyrazole-4-Carbo supplier Onconova has conducted trials with two other research compounds and has a pre-clinical program with a CDK4/6 and Ark5 inhibitor, ON 123300. 5-(Aminosulfonyl)-1-Methyl-1H- Pyrazole-4-Carbo vendor Right now, midstage data for Roche-AC Immune’s anti-tau antibody semorinemab in moderate Alzheimer’s are expected later this year, but it has already failed a phase 2 study in mild disease. 5-(Aminosulfonyl)-1-Methyl-1H- Pyrazole-4-Carbo factory Of the nearly 4,000 Black women and more than 25,000 white women included in the study, there was no statistically significant difference in breast cancer-related genetic mutations. They were found in 5.65% of Black women and nearly 5.1% of white women.
